"Anemia, Sickle Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
Descriptor ID |
D000755
|
MeSH Number(s) |
C15.378.071.141.150.150 C15.378.420.155 C16.320.070.150 C16.320.365.155
|
Concept/Terms |
Anemia, Sickle Cell- Anemia, Sickle Cell
- Anemias, Sickle Cell
- Sickle Cell Anemias
- Hemoglobin S Disease
- Disease, Hemoglobin S
- Hemoglobin S Diseases
- Sickle Cell Anemia
- Sickle Cell Disorders
- Cell Disorder, Sickle
- Cell Disorders, Sickle
- Sickle Cell Disorder
- Sickling Disorder Due to Hemoglobin S
- HbS Disease
- Sickle Cell Disease
- Cell Disease, Sickle
- Cell Diseases, Sickle
- Sickle Cell Diseases
|
Below are MeSH descriptors whose meaning is more general than "Anemia, Sickle Cell".
- Diseases [C]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Anemia [C15.378.071]
- Anemia, Hemolytic [C15.378.071.141]
- Anemia, Hemolytic, Congenital [C15.378.071.141.150]
- Anemia, Sickle Cell [C15.378.071.141.150.150]
- Hemoglobinopathies [C15.378.420]
- Anemia, Sickle Cell [C15.378.420.155]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Anemia, Hemolytic, Congenital [C16.320.070]
- Anemia, Sickle Cell [C16.320.070.150]
- Hemoglobinopathies [C16.320.365]
- Anemia, Sickle Cell [C16.320.365.155]
Below are MeSH descriptors whose meaning is more specific than "Anemia, Sickle Cell".
This graph shows the total number of publications written about "Anemia, Sickle Cell" by people in this website by year, and whether "Anemia, Sickle Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 6 | 0 | 6 |
1996 | 4 | 0 | 4 |
1997 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2001 | 3 | 1 | 4 |
2002 | 2 | 0 | 2 |
2003 | 2 | 1 | 3 |
2004 | 2 | 0 | 2 |
2005 | 3 | 0 | 3 |
2006 | 4 | 0 | 4 |
2007 | 4 | 1 | 5 |
2008 | 5 | 1 | 6 |
2009 | 4 | 0 | 4 |
2010 | 8 | 0 | 8 |
2011 | 13 | 2 | 15 |
2012 | 5 | 1 | 6 |
2013 | 9 | 1 | 10 |
2014 | 6 | 1 | 7 |
2015 | 4 | 1 | 5 |
2016 | 8 | 1 | 9 |
2017 | 8 | 2 | 10 |
2018 | 8 | 1 | 9 |
2019 | 13 | 0 | 13 |
2020 | 11 | 0 | 11 |
2021 | 6 | 0 | 6 |
2022 | 18 | 0 | 18 |
2023 | 11 | 0 | 11 |
2024 | 11 | 1 | 12 |
2025 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anemia, Sickle Cell" by people in Profiles.
-
Outcomes on the use of hyperhemolysis prophylaxis in pediatric sickle cell disease patients with history of hyperhemolysis syndrome. Transfusion. 2025 May; 65(5):1001-1006.
-
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease. Blood Adv. 2025 Mar 11; 9(5):955-965.
-
Engaging Parents of Children With Sickle Cell Disease in Shared Decision-Making for Hydroxyurea: The ENGAGE-HU Study. Pediatr Blood Cancer. 2025 May; 72(5):e31639.
-
Sickle cell disease gene therapy drug expenses and reimbursement: a litmus test for commercial pricing strategy and patient access for curative therapies. Cytotherapy. 2025 May; 27(5):567-570.
-
A multiplexed, allele-specific recombinase polymerase amplification assay with lateral flow readout for sickle cell disease detection. Lab Chip. 2024 08 20; 24(17):4115-4127.
-
Impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell disease. Blood. 2024 08 08; 144(6):672-675.
-
Cell and gene therapy accessibility. Science. 2024 08 02; 385(6708):475.
-
Splenic complications in pediatric sickle cell disease: A retrospective cohort review. Pediatr Blood Cancer. 2024 Oct; 71(10):e31219.
-
Concomitant sickle cell disease and systemic lupus erythematosus: A single-center case series. Pediatr Blood Cancer. 2024 Oct; 71(10):e31194.
-
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series. Pediatr Blood Cancer. 2024 Aug; 71(8):e31061.